Change at the top for Teleflex as Black resigns
This article was originally published in Clinica
Jeffrey Black has resigned as the CEO of Teleflex after more than ten years in the position. The Menlo Park, California-based company said that Mr Black had resigned by mutual agreement but did not specify his reasons for departing. Benson Smith has become the firm’s new chairman, president and CEO of Teleflex, which is striving to become a pure-play medtech firm. Mr Smith has been a Teleflex board member since 2005; before joining the firm he spent 25 years at CR Bard, where he most recently held the role of president and chief operating officer. He is also chairman of cardiac resuscitation and AED firm Zoll Medical and a board member at urological catheter specialist Rochester Medical. Teleflex is focusing its operations on the medical device market – it recently purchased catheter navigation firm VasoNova for $55m (www.clinica.co.uk, 11 January 2011) and agreed to sell the actuation business of its Telair International subsidiary (www.clinica.co.uk, 2 December 2010).
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals